Dragicevic D - Search Results

1

Morphology of Balkan endemic nephropathy: current state.

Markovic-Lipkovski J, Tulic C, Vuksanovic A, Dragicevic D, Dokic M, Tatic S, Lezaic V. Markovic-Lipkovski J, et al. Among authors: dragicevic d. Clin Nephrol. 2012 Jan;77(1):25-31. Clin Nephrol. 2012. PMID: 22185965

2

[Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia].

Djokic M, Hadzi-Djokic J, Nikolic J, Dragicevic D, Radivojevic D. Djokic M, et al. Among authors: dragicevic d. Prog Urol. 1999 Feb;9(1):61-8. Prog Urol. 1999. PMID: 10212954 French.

3

Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia.

Dragicevic D, Djokic M, Pekmezovic T, Micic S, Hadzi-Djokic J, Vuksanovic A, Simic T. Dragicevic D, et al. BJU Int. 2007 Jun;99(6):1357-62. doi: 10.1111/j.1464-410X.2007.06793.x. Epub 2007 Mar 6. BJU Int. 2007. PMID: 17346272

4

Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma.

Simic T, Dragicevic D, Savic-Radojevic A, Cimbaljevic S, Tulic C, Mimic-Oka J. Simic T, et al. Among authors: dragicevic d. Int J Urol. 2007 Apr;14(4):289-93. doi: 10.1111/j.1442-2042.2006.01719.x. Int J Urol. 2007. PMID: 17470155

5

Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways.

Pljesa-Ercegovac M, Savic-Radojevic A, Dragicevic D, Mimic-Oka J, Matic M, Sasic T, Pekmezovic T, Vuksanovic A, Simic T. Pljesa-Ercegovac M, et al. Among authors: dragicevic d. Urol Oncol. 2011 Jan-Feb;29(1):70-7. doi: 10.1016/j.urolonc.2008.10.019. Epub 2009 Jan 21. Urol Oncol. 2011. PMID: 19162514

6

Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma.

Dragicevic D, Djokic M, Pekmezovic T, Vuksanovic A, Micic S, Hadzi-Djokic J, Tulic C, Milenkovic D, Pljesa-Ercegovac M, Simic T. Dragicevic D, et al. Urol Int. 2009;82(3):335-40. doi: 10.1159/000209368. Epub 2009 May 11. Urol Int. 2009. PMID: 19440024

7

Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival.

Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Dragicevic D, Bumbasirevic U, Tulic C. Milojevic B, et al. Among authors: dragicevic d. Int Urol Nephrol. 2011 Sep;43(3):729-35. doi: 10.1007/s11255-011-9902-4. Epub 2011 Feb 26. Int Urol Nephrol. 2011. PMID: 21350863

8

Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.

Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Bumbasirevic U, Vukovic I, Dragicevic D, Tulic C. Milojevic B, et al. Among authors: dragicevic d. BJU Int. 2012 Apr;109(7):1037-42. doi: 10.1111/j.1464-410X.2011.10461.x. Epub 2011 Aug 25. BJU Int. 2012. PMID: 21883837

9

Renal cancer and Wegener's granulomatosis: a case report.

Bumbasirevic U, Dragicevic D, Janicic A, Cemerikic-Martinovic V, Cekerevac M, Aleksic V, Tulic C. Bumbasirevic U, et al. Among authors: dragicevic d. World J Surg Oncol. 2011 Dec 13;9:165. doi: 10.1186/1477-7819-9-165. World J Surg Oncol. 2011. PMID: 22166090 Free PMC article.

10

GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.

Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V, Simic T. Matic M, et al. Among authors: dragicevic d. Urol Oncol. 2013 Oct;31(7):1184-92. doi: 10.1016/j.urolonc.2011.08.005. Urol Oncol. 2013. PMID: 24075358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page